Molecular tests as prognostic factors in breast cancer

Overview of attention for article published in Virchows Archiv, February 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 60 Mendeley
citeulike: 1 CiteULike

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 11,080 followers.

RT @LizaMQuintana: 3/ Biomarkers are evaluated in routine clinical mgmt of patients with breast cancer. The 3 routinely tested: Hormone re…

21 Nov 2020

Reply Repost Favourite

RT @LizaMQuintana: 3/ Biomarkers are evaluated in routine clinical mgmt of patients with breast cancer. The 3 routinely tested: Hormone re…

20 Nov 2020

Reply Repost Favourite

3/ Biomarkers are evaluated in routine clinical mgmt of patients with breast cancer. The 3 routinely tested: Hormone receptors (HR): Estrogen receptor (ER) and Progesterone receptor (PR) & Human epidermal growth factor receptor 2 (HER2) (chart from: